A systematic review and meta‐analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections

H Kato, M Hagihara, N Asai, T Umemura, J Hirai… - Mycoses, 2023 - Wiley Online Library
Background Isavuconazole is a novel triazole antifungal agent. However, the previous
outcomes were highlighted by statistical heterogeneity. This meta‐analysis aimed to validate …

The disease burden of mucormycosis in Japan: Results from a systematic literature review and retrospective database study

R Ueno, S Nishimura, G Fujimoto… - … Medical Research and …, 2021 - Taylor & Francis
Objective To evaluate outcomes, healthcare resource utilization, and costs associated with
mucormycosis in inpatient settings in Japan. Methods We performed a systematic literature …

The double-edged sword of immunosuppressive therapy in kidney transplantation: a rare case report of pulmonary mucormycosis post-transplant and literature review

H Zhang, K Wang, H Chen, L Sun, Z Wang, S Fei… - Frontiers in …, 2020 - frontiersin.org
Immunosuppressive therapy is improving the graft survival of kidney transplant recipients
and increasing the potential risk of infection. Pulmonary mucormycosis is a rare post …

Comparative activity of posaconazole and systemic azole agents against clinical isolates of filamentous fungi from a global surveillance programme

CG Carvalhaes, PR Rhomberg, M Pfaller… - JAC-Antimicrobial …, 2021 - academic.oup.com
Objectives The activity of mould-active azoles was evaluated against 397 filamentous fungi
causing invasive mould infections (IMI) worldwide. In addition, a tentative posaconazole …

[HTML][HTML] Fungal symptomatic intracranial aneurysm treated with a flow diverting stent: A case report

Y Fujimi, T Ozaki, N Izutsu, S Nakajima… - Surgical Neurology …, 2024 - ncbi.nlm.nih.gov
Background: Intracranial infectious aneurysms (IIAs) are very rare, and fungal aneurysms
are infrequently reported. We report a case of an unruptured IIA caused by fungal …

[HTML][HTML] Factores de Riesgo de Mortalidad en Pacientes Hematológicos con Aspergilosis Pulmonar en Clínica Médica Instituto de Previsión Social-Hospital Central …

FB Rivaldi Montenegro… - Revista del Instituto …, 2021 - scielo.iics.una.py
ResumenIntroducción: Es una de las infecciones oportunistas de mayor impacto en el
paciente con patologías hematooncológicas, su detección precoz y tratamiento oportuno …

Mortality Risk Factors in Hematological Patients with Pulmonary Aspergillosis at the Medical Clinic Instituto de Prevision Social-Hospital Central. Year 2016 to 2018

FB Rivaldi Montenegro… - Revista del Instituto …, 2021 - scielo.iics.una.py
Abstract RIVALDI MONTENEGRO, Fabiola Beatriz et al. Mortality Risk Factors in
Hematological Patients with Pulmonary Aspergillosis at the Medical Clinic Instituto de …

[PDF][PDF] Factores de Riesgo de Mortalidad en Pacientes Hematológicos con Aspergilosis Pulmonar en Clínica Médica Instituto de Previsión Social–Hospital Central …

FBR Montenegro, RRR Leiva, JG Oliveira, AMJ Luchuk… - scholar.archive.org
Introducción: Es una de las infecciones oportunistas de mayor impacto en el paciente con
patologías hematooncológicas, su detección precoz y tratamiento oportuno impide su …